Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Edaravone oral - Auzone Biological Technology

X
Drug Profile

Edaravone oral - Auzone Biological Technology

Alternative Names: TTYP 01

Latest Information Update: 22 Jan 2025

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Suzhou Auzone Biological Technology
  • Class Anti-ischaemics; Antidementias; Antihaemorrhagics; Antiparkinsonians; Hepatoprotectants; Neuroprotectants; Pyrazolones; Small molecules; Vascular disorder therapies
  • Mechanism of Action Antioxidants; Free radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Stroke
  • Phase II Pervasive child development disorders
  • No development reported Amyotrophic lateral sclerosis

Most Recent Events

  • 07 Jan 2025 Phase-II clinical trials in Pervasive child development disorders (In adolescents, In children) in China (PO) (NCT06757504)
  • 27 Dec 2024 Shanghai Auzone Biological plans a phase II trial for Autistic disorder (In children, In adolescents) in China (PO), in December 2024 (NCT06757504)
  • 17 Jun 2024 Auzone Biological Technology completes a phase-III clinical trials in Stroke in China (PO) (NCT06648304)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top